SCHEMBL2249737

SCHEMBL2249737

CS(=O)(=O)N1CCc2nc(NCCCC3CCNCC3)ncc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 5/20 0.40
CHEK1 O14757 3/20 0.40
CDK2 P24941 2/20 0.40
KIT P10721 2/20 0.40
AURKA O14965 1/20 0.40
RPS6KA5 O75582 1/20 0.40
RPS6KA4 O75676 1/20 0.40
RPS6KB1 P23443 1/20 0.40
RPS6KA3 P51812 1/20 0.40
RPS6KA2 Q15349 1/20 0.40
RPS6KA1 Q15418 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
RPS6KB2 Q9UBS0 1/20 0.40
RPS6KA6 Q9UK32 1/20 0.40
MAPK1 P28482 1/20 0.38
MERTK Q12866 6/20 0.38
TYRO3 Q06418 4/20 0.38
AXL P30530 3/20 0.38
HRH4 Q9H3N8 5/20 0.37
GAS6 Q14393 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407169 0.86 NAMPT (0.40) FLT3CHEK1CDK2KITAURKA
SCHEMBL2243836 0.83 GPR119 (0.51) FLT3CHEK1CDK2KITAURKA
SCHEMBL2248670 0.82 ITGB3 (0.36) HSP90AA1CNR2
SCHEMBL2246087 0.82 GPR119 (0.48)
SCHEMBL2250016 0.81 GPR119 (0.42) FLT3CHEK1CDK2KITAURKA
SCHEMBL2252146 0.80 GPR119 (0.53) FLT3CHEK1CDK2KITAURKA
SCHEMBL21656758 0.78 HSP90AA1 (0.48) FLT3CHEK1CDK2KITAURKA
SCHEMBL3407090 0.75 F12 (0.35) CDK2MAPK1HSP90AA1CNR2CCNE1
SCHEMBL29724780 0.70 JAK2 (0.45) FLT3CHEK1CDK2KITAURKA
SCHEMBL12288617 0.70 JAK2 (0.45) FLT3CHEK1CDK2KITAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190263-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-08-04 US disclosed
US-20110190263-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-08-04 US disclosed
US-20110190263-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-08-04 US disclosed
WO-2009105717-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190263-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 FLT3 2479/4885CHEK1 4493/4885CDK2 2582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.